{
  "schema_version": "1",
  "accession_number": "0001193125-26-189477",
  "cik": "0001540171",
  "filer_name": "Avalyn Pharma Inc.  (AVLN)  (CIK 0001540171)",
  "sic_code": "2834",
  "form_type": "S-1/A",
  "is_amendment": true,
  "filed_at": "2026-04-29T00:00:00.000Z",
  "indexed_at": "2026-04-29T16:44:06.916Z",
  "edgar_url": "https://www.sec.gov/Archives/edgar/data/1540171/000119312526189477/0001193125-26-189477-index.htm",
  "secfilingdex_url": "https://secfilingdex.com/filing/0001193125-26-189477/",
  "license": "U.S. government works are public domain (17 U.S.C. § 105). Editorial annotations CC-BY-4.0.",
  "source": "SEC EDGAR"
}